611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line
1-877-756-4090

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Cancer
Resources
Basic InformationLatest News
Could the U.S. Mail Deliver Better Colon Cancer Screening Rates?Baby Monkey May Offer Hope to Preserving Fertility of Kids With CancerDrug Combo Does Double Duty Against Common Skin Lesions, CancersTecentriq Approved for Small Cell Lung CancerHormonal Therapy for Prostate Cancer Might Raise Depression RiskGenomics Could Improve Treatment of Pancreatic CancerScientists Spot Clues to Predicting Breast Cancer's ReturnAI Takes Aim at Lung Cancer Screening'Jeopardy!' Host Alex Trebek Reveals He Has Pancreatic CancerLow-Dose Aspirin Doesn't Prolong Survival in Prostate CancerExercise Might Slow Colon Cancer's AdvanceHigh Deductibles May Threaten Breast Cancer Patients' SurvivalLifestyle Changes Can Lower Your Breast Cancer RiskCould Invasive Lung Cancer Biopsies Be Replaced by Blood Tests?Colon Cancer Usually Diagnosed Late in Under-50 AdultsHigh-Fiber Diet May Help Gut 'Microbiome' Battle MelanomaAlmost Half of Global Cases of Childhood Cancer Go UndiagnosedTesticular Cancer Treatment Doesn't Always Doom FertilitySingle Dose of Keytruda May Help Put Melanoma Into RemissionCervical 'Microbiome' Could Help Predict Cancer RiskSmokers May Fare Worse Against the Deadliest Skin CancerAHA News: Cancers of the Heart Are Rare -- and Here's WhyMost Nations May Be Rid of Cervical Cancer By 2100Experimental Drug Helps Women With Deadly Type of Breast CancerAre Primary Care Doctors Prepared to Discuss Cancer Treatment?Should You Get Tested for the 'Breast Cancer Genes'?Kidney Failure Patients Face Higher Risk of Cancer DeathDespite Gains, Black Americans Still Have Highest Cancer Death RateBreast Cancer and DDT: Timing of Exposure May MatterMore U.S. Men Holding Off on Prostate Cancer SurgeryAspirin Can Help Prevent Colon Cancer, But Many at Risk Don't Take ItOne Key Step Can Help Cancer Patients Quit SmokingFertility Treatments Don't Raise Cancer Risk for OffspringToo Much TV Raises Women's Odds for Early-Onset Colon Cancer: StudyObesity-Linked Cancers On the Rise Among Young AmericansHead, Neck Cancers Up Among 9-11 Responders: StudyHealth Tip: Symptoms of Neuropathy Caused By ChemoBreast Cancer May Bring Higher Odds for A-fib, TooHealth Tip: Help Prevent Cervical CancerAdding Blood Test for Pancreatic Cancer May Aid Early DetectionMany Cancer Patients Have Undiagnosed HepatitisAcupressure Is Good Medicine for Breast Cancer SurvivorsProstate Drug Finasteride Can Safely Lower Cancer Risk, Study SaysHealth Tip: Evaluating a New Cancer TreatmentAt Risk for Breast Cancer? Your Race MattersMany Oncologists in the Dark About LGBTQ Health NeedsCancer Diagnosis May Quadruple Suicide RiskMake Cancer Prevention a Priority in 2019Even a Little Exercise May Help Cancer Patients Live LongerHealth Tip: Nurture Your Emotional Health as a Cancer Patient
LinksBook ReviewsSelf-Help Groups
Related Topics

Medical Disorders
Pain Management

Genomics Could Improve Treatment of Pancreatic Cancer

HealthDay News
by -- Robert Preidt
Updated: Mar 14th 2019

new article illustration

THURSDAY, March 14, 2019 (HealthDay News) -- It's one of the toughest cancers to beat. But new research suggests that identifying the genetics of pancreatic cancer in individual patients could boost survival for some.

The five-year survival rate for pancreatic cancer patients is less than 9 percent. One reason this cancer is so deadly is that many patients are diagnosed at a late stage and often with inoperable tumors.

In some cases, existing chemotherapy drugs might be able to shrink pancreatic tumors if the disease is diagnosed early enough.

In this study, University of Pittsburgh researchers analyzed the genomes of nearly 3,600 pancreatic tumor samples from around the world. In 17 percent, genetics suggested the tumor would respond to existing chemotherapy drugs.

The team also found evidence of hereditary genes -- including some in the BRCA family associated with breast cancer -- that can increase an entire family's risk of pancreatic cancer.

"People have been looking for such markers for a long time, and our study shows that it's possible to break pancreatic cancer patients into different treatment buckets," senior author Dr. Nathan Bahary, an associate professor of medicine, said in a university news release.

Lead author Dr. Aatur Singhi, an assistant professor of pathology, noted that every pancreatic cancer is different. Developing a molecular profile of each patient's tumor could help determine the best treatments, he said.

"Rather than blindly giving patients the same chemotherapy, we want to tailor a patient's chemo to their tumor type. A one-size-fits-all approach isn't going to work. Therefore, we would like to make molecular profiling standard of care for patients with pancreatic cancer," Singhi said in the news release.

The study was recently published online in the journal Gastroenterology.

Singhi and colleagues previously developed a test to evaluate common pancreatic cysts and identify which might progress to cancer. These newly discovered biomarkers can be added to the test, which is already in use at several institutions.

More information

The U.S. National Cancer Institute has more on pancreatic cancer.